Lorenza Rimassa, Associate Professor of Medical Oncology at Humanitas University shared on LinkedIn:
“Traveling to Madrid for ESMO26.
I look forward to meeting with friends and colleagues and discussing novel treatment options for patients with.
- HCC – Hepatocellular carcinoma
- BTC – Biliary tract cancer
- CCA – Cholangiocarcinoma
- PDAC – Pancreatic ductal adenocarcinoma
Stay tuned for updates on HPB cancers.”
European Society for Medical Oncology, added:
“Attending ESMO26?
Remember to share your experience with us.
When posting from or about the congress, don’t forget to use ‘ESMO26’ to join the conversation and connect with the global oncology community.
Together we can make ESMO26 an unforgettable experience”
You may also be interested in:
Lorenza Rimassa: Looking Ahead to the Future of GI Oncology
